NM_024105.4:c.117delG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024105.4(ALG12):c.117delG(p.Gln40ArgfsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L39L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024105.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- ALG12-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024105.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG12 | NM_024105.4 | MANE Select | c.117delG | p.Gln40ArgfsTer34 | frameshift | Exon 2 of 10 | NP_077010.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG12 | ENST00000330817.11 | TSL:1 MANE Select | c.117delG | p.Gln40ArgfsTer34 | frameshift | Exon 2 of 10 | ENSP00000333813.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251368 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461800Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727192 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ALG12-congenital disorder of glycosylation Pathogenic:3
This sequence change creates a premature translational stop signal (p.Gln40Argfs*34) in the ALG12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALG12 are known to be pathogenic (PMID: 15639192, 31481313). This variant is present in population databases (rs761221480, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with clinical features of ALG12-congenital disorder of glycosylation (PMID: 25019053). ClinVar contains an entry for this variant (Variation ID: 242855). For these reasons, this variant has been classified as Pathogenic.
This variant was found in trans with pathogenic variant NM_024105.3:c.1001delA in an individual with congenital disorder of glycosylation type Ig.
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31529350, 31481313, 34441372, 25019053)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at